1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. Zylox-Tonbridge Medical Technology Co., Ltd.
  6. Summary
    2190   CNE100004JD2

ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.

(2190)
  Report
Delayed Hong Kong Stock Exchange  -  04:08 2022-08-12 am EDT
10.70 HKD    0.00%
07/04201,881,003 Domestic Shares of Zylox-Tonbridge Medical Technology Co., Ltd. are subject to a Lock-Up Agreement Ending on 4-JUL-2022.
CI
07/0461,519,998 H Shares of Zylox-Tonbridge Medical Technology Co., Ltd. are subject to a Lock-Up Agreement Ending on 4-JUL-2022.
CI
04/13China Grants Marketing Approval to Zylox-Tonbridge's Angioplasty Balloon Catheter
MT
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Hong Kong Stock Exchange
08/08/2022 08/09/2022 08/10/2022 08/11/2022 08/12/2022 Date
10.28(c) 10.14(c) 10.98(c) 10.7(c) 10.7(c) Last
10 500 16 000 105 281 28 500 2 000 Volume
+0.19% -1.36% +8.28% -2.55% 0.00% Change
More quotes
Estimated financial data (e)
Sales 2022 324 M 48,1 M 48,1 M
Net income 2022 - - -
Net cash position 2022 2 226 M 330 M 330 M
P/E ratio 2022 -
Yield 2022 -
Sales 2023 552 M 81,9 M 81,9 M
Net income 2023 - - -
Net cash position 2023 2 140 M 317 M 317 M
P/E ratio 2023 -
Yield 2023 -
Capitalization 3 059 M 454 M 454 M
EV / Sales 2022 2,57x
EV / Sales 2023 1,67x
Nbr of Employees 487
Free-Float 31,1%
More Financials
Company
Zylox-Tonbridge Medical Technology Co Ltd, formerly Zylox Medical Device Co Ltd, is a China-based company mainly engaged in the research and development of neurological and peripheral vascular interventional medical devices. The Company's main products include Thrombite Clot Retriever Device (Thrombite CRD) and Ultrafree Drug Coated PTA Balloon Catheter (Ultrafree DCB). The Company's products are sold to domestic... 
More about the company
Ratings of Zylox-Tonbridge Medical Technology Co., Ltd.
Trading Rating :  -
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
07/04201,881,003 Domestic Shares of Zylox-Tonbridge Medical Technology Co., Ltd. are subject..
CI
07/0461,519,998 H Shares of Zylox-Tonbridge Medical Technology Co., Ltd. are subject to a Lo..
CI
04/13China Grants Marketing Approval to Zylox-Tonbridge's Angioplasty Balloon Catheter
MT
04/12Zylox-Tonbridge Medical Technology Co., Ltd. Announces National Medical Products Admini..
CI
04/11China Grants Marketing Nod to Zylox-Tonbridge's Carotid Balloon Catheter
MT
04/08Zylox-Tonbridge Medical Technology Co., Ltd. Updates Business and New Product Developme..
CI
04/07Zylox-Tonbridge Medical Technology Co., Ltd. Announces Management Changes
CI
03/15Zylox-Tonbridge Medical Widens Loss as Expenses Surge in 2021
MT
03/15Zylox-Tonbridge Medical Technology Co., Ltd. Reports Earnings Results for the Full Year..
CI
03/03ZYLOX TONBRIDGE MEDICAL TECHNOLOGY : Announcement regarding completion of the h share full..
PU
02/14Zylox-Tonbridge Warns of 'Significant' FY21 Loss Despite Sixfold Jump in Revenue; Share..
MT
01/17Zylox-Tonbridge Invests in China-based Wire Sciences Medical
MT
01/17Wire Sciences Medical Technology Co., Ltd announced that it expects to receive funding ..
CI
01/0426,356,000 H Shares of Zylox-Tonbridge Medical Technology Co., Ltd. are subject to a Lo..
CI
2021ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY C : 2190) added to S&P Global BMI Index
CI
More news
News in other languages on ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
04/13La Chine accorde une autorisation de commercialisation au cathéter à ballonnet pour ang..
04/12Zylox-Tonbridge Medical Technology Co., Ltd. annonce que l'administration nationale des..
04/11La Chine accorde un feu vert à la commercialisation du cathéter à ballonnet carotidien ..
04/08Zylox-Tonbridge Medical Technology Co., Ltd. Mise à jour des activités et développement..
04/07Zylox-Tonbridge Medical Technology Co., Ltd. annonce des changements de direction
More news
Chart ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
Duration : Period :
Zylox-Tonbridge Medical Technology Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 9,20 CNY
Average target price 18,07 CNY
Spread / Average Target 96,4%
Managers and Directors
Zhong Zhao Chairman & Chief Executive Director
Quan Wei Yuan Chief Financial Officer & Joint Secretary
Jian Ji Independent Non-Executive Director
Hong Ze Liang Independent Non-Executive Director
Yun Qiu Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.-58.04%453
STRYKER CORPORATION-18.48%82 478
SMITH & NEPHEW PLC-17.70%11 299
INSPIRE MEDICAL SYSTEMS, INC.-1.56%6 259
AXONICS, INC.25.14%3 443
GLAUKOS CORPORATION12.51%2 378